JP Morgan analyst Christyan Malek downgrades TotalEnergies (NYSE:TTE) from Overweight to Neutral.
Raymond James Maintains Strong Buy on Health Catalyst, Lowers Price Target to $15
Raymond James analyst John Ransom maintains Health Catalyst (NASDAQ:HCAT) with a Strong Buy and lowers the price target from $20 to $15.